Clinical Trials Directory

Trials / Completed

CompletedNCT07294911

Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome

Predictors of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Karaganda Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This observational study aims to identify predictors of contrast-induced acute kidney injury (CI-AKI) in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clinical, laboratory, and procedural factors will be analyzed to determine their association with the development of CI-AKI. The findings may help improve risk stratification and preventive strategies in this high-risk population.

Detailed description

This prospective observational study investigates predictors of contrast-induced acute kidney injury (CI-AKI) among patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). The study was conducted from November 2024 to June 2025 at a tertiary cardiac center. Patients with ACS who underwent coronary angiography or PCI were enrolled consecutively. Clinical characteristics, laboratory parameters, hydration status, use of nephrotoxic drugs, and type and volume of contrast media were recorded. Serum creatinine levels were measured before and 48-72 hours after contrast exposure, and CI-AKI was defined according to KDIGO criteria. The primary objective is to identify independent predictors of CI-AKI using multivariate analysis. Secondary objectives include evaluation of short-term outcomes, such as in-hospital complications and renal function recovery at 90 days. The results are expected to improve understanding of CI-AKI risk in real-world ACS patients and to support preventive strategies in interventional cardiology.

Conditions

Interventions

TypeNameDescription
OTHERObservational data collectionData collected from routine clinical care to evaluate predictors of contrast-induced acute kidney injury after PCI. No intervention applied.

Timeline

Start date
2024-11-02
Primary completion
2025-06-02
Completion
2025-09-02
First posted
2025-12-19
Last updated
2025-12-19

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT07294911. Inclusion in this directory is not an endorsement.